Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 9 (March 20), 2005: pp. 1902-1910
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.07.102

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gritz, E. R.
Right arrow Articles by Lynch, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gritz, E. R.
Right arrow Articles by Lynch, P. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Psychological Impact of Genetic Testing for Hereditary Nonpolyposis Colorectal Cancer

Ellen R. Gritz, Susan K. Peterson, Sally W. Vernon, Salma K. Marani, Walter F. Baile, Beatty G. Watts, Christopher I. Amos, Marsha L. Frazier, Patrick M. Lynch

From The University of Texas M.D. Anderson Cancer Center; and the University of Texas Health Science Center at Houston School of Public Health, Houston, TX

Address reprint requests to Ellen R. Gritz, PhD, Department of Behavioral Science, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd 243, Houston, TX 77030-4009; e-mail: egritz{at}mdanderson.org

PURPOSE: This study examines the impact of hereditary nonpolyposis colorectal cancer (HNPCC) genetic test results on psychological outcomes among cancer-affected and -unaffected participants up to 1 year after results disclosure.

PATIENTS AND METHODS: A total of 155 persons completed study measures before HNPCC genetic testing, and at 2 weeks and 6 and 12 months after disclosure of test results.

RESULTS: Mean scores on all outcome measures remained stable and within normal limits for cancer-affected participants, regardless of mutation status. Among unaffected carriers of HNPCC-predisposing mutations, mean depression, state anxiety, and cancer worries scores increased from baseline to 2 weeks postdisclosure and decreased from 2 weeks to 6 months postdisclosure. Among unaffected noncarriers, mean depression and anxiety scores did not differ, but cancer worries scores decreased during the same time period. Affected and unaffected carriers had higher mean test-specific distress scores at 2 weeks postdisclosure compared with noncarriers in their respective groups; scores decreased for affected carriers and all unaffected participants from 2 weeks to 12 months postdisclosure. Classification of participants into high- versus low-distress clusters using mean scores on baseline psychological measures predicted significantly higher or lower follow-up scores, respectively, on depression, state anxiety, quality of life, and test-specific distress measures, regardless of mutation status.

CONCLUSION: Although HNPCC genetic testing does not result in long-term adverse psychological outcomes, unaffected mutation carriers may experience increased distress during the immediate postdisclosure time period. Furthermore, those with higher levels of baseline mood disturbance, lower quality of life, and lower social support may be at risk for both short- and long-term increased distress.

Supported by grant No. R01HG01200, National Human Genome Institute, National Institutes of Health, Bethesda, MD, to E.R.G., principal investigator.

Authors' disclosures of potential conflicts of interest are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Psychosom. Med.Home page
A. L. Dougall, A. W. Smith, T. J. Somers, D. M. Posluszny, W. S. Rubinstein, and A. Baum
Coping With Genetic Testing for Breast Cancer Susceptibility
Psychosom Med, January 1, 2009; 71(1): 98 - 105.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
K Aktan-Collan, A Haukkala, K Pylvanainen, H J Jarvinen, L A Aaltonen, P Peltomaki, E Rantanen, H Kaariainen, and J-P Mecklin
Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing
J. Med. Genet., November 1, 2007; 44(11): 732 - 738.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
N. J. Kerruish, P. L. Campbell-Stokes, A. Gray, T. R. Merriman, S. P. Robertson, and B. J. Taylor
Maternal Psychological Reaction to Newborn Genetic Screening for Type 1 Diabetes
Pediatrics, August 1, 2007; 120(2): e324 - e335.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online